HIV Mutation Detail Information

> K65K Search Result

Mutation Information

Mutation Site	K65K
Mutation Type	Amino acid level
Gene/Protein/Region Type	RT
Relevant Drug	NRTIs

Literature Information

PubMed PMID	30352054
Disease	HIV infection/AIDS
Published Year	2018
Journal	PloS one
Title	Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial.
Author	Morales-Ramirez J,Bogner JR,Molina JM,Lombaard J,Dicker IB,Stock DA,DeGrosky M,Gartland M,Pene Dumitrescu T,Min S,Llamoso C,Joshi SR,Lataillade M
Evidence	Ne participant in the GSK3532795 180 mg arm developed NRTI mutations M184V and K65K/R, and another participant in the GSK3532795 60 mg arm had emergent M184V and K70K/E.

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation